Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)

Metformin is an oral anti-hyperglycemic agent in the biguanide class which lowers blood glucose concentrations and has been used to treat type 2 diabetes mellitus. Metformin is highly used in polycystic ovary syndrome (PCOS), premature puberty, and non-alcoholic fatty liver disease (NAFLD). A brain...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Hassan, Marwa Fouad Al (author)
التنسيق: masterThesis
منشور في: 2016
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/10725/3259
https://doi.org/10.26756/th.2014.63
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513460924055552
author Hassan, Marwa Fouad Al
author_facet Hassan, Marwa Fouad Al
author_role author
dc.creator.none.fl_str_mv Hassan, Marwa Fouad Al
dc.date.none.fl_str_mv 2016-03-03T13:32:28Z
2016-03-03T13:32:28Z
2016-03-03
5/15/2014
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/3259
https://doi.org/10.26756/th.2014.63
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Metformin -- Therapeutic use
Astrocytomas
Brain -- Tumors
Cells -- Motility
Cell proliferation -- Drug effects
Cell adhesion
Lebanese American University -- Dissertations
Dissertations, Academic
dc.title.none.fl_str_mv Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Metformin is an oral anti-hyperglycemic agent in the biguanide class which lowers blood glucose concentrations and has been used to treat type 2 diabetes mellitus. Metformin is highly used in polycystic ovary syndrome (PCOS), premature puberty, and non-alcoholic fatty liver disease (NAFLD). A brain tumor is an intracranial solid neoplasm which is a tumor within the brain or the central spinal canal. According to the World Health Organization (WHO), primary brain tumors are classified according to their histological characteristics and cellular origin. In addition, gliomas, which belong to the neuroepithelial brain tumors, include oligodendroglioma, astrocytoma, ependymoma, mixed glioma, and glioblastoma. Previous studies showed a cytotoxic effect of metformin on ovarian cells. This prompted us, in our current study, to investigate the effect of metformin on the proliferation and metastasis astrocytoma. When this drug is applied, it led to a relative decrease in the proliferation of astrocytoma cancer cells. Metformin treatment also resulted in a drastic inhibition of 2D cell motility and an increase in cellular adhesion. Hence, our study shows that Metformin could be used as an anti-metastatic drug in brain tumor.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_50c8d58f76341cda7316ab654e43d764
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/3259
publishDate 2016
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)Hassan, Marwa Fouad AlMetformin -- Therapeutic useAstrocytomasBrain -- TumorsCells -- MotilityCell proliferation -- Drug effectsCell adhesionLebanese American University -- DissertationsDissertations, AcademicMetformin is an oral anti-hyperglycemic agent in the biguanide class which lowers blood glucose concentrations and has been used to treat type 2 diabetes mellitus. Metformin is highly used in polycystic ovary syndrome (PCOS), premature puberty, and non-alcoholic fatty liver disease (NAFLD). A brain tumor is an intracranial solid neoplasm which is a tumor within the brain or the central spinal canal. According to the World Health Organization (WHO), primary brain tumors are classified according to their histological characteristics and cellular origin. In addition, gliomas, which belong to the neuroepithelial brain tumors, include oligodendroglioma, astrocytoma, ependymoma, mixed glioma, and glioblastoma. Previous studies showed a cytotoxic effect of metformin on ovarian cells. This prompted us, in our current study, to investigate the effect of metformin on the proliferation and metastasis astrocytoma. When this drug is applied, it led to a relative decrease in the proliferation of astrocytoma cancer cells. Metformin treatment also resulted in a drastic inhibition of 2D cell motility and an increase in cellular adhesion. Hence, our study shows that Metformin could be used as an anti-metastatic drug in brain tumor.N/A1 hard copy: xiv, 33 leaves.; ill.; 30 cm. available at RNL.Includes bibliographical references (leaves 25-33).Lebanese American University2016-03-03T13:32:28Z2016-03-03T13:32:28Z5/15/20142016-03-03Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/3259https://doi.org/10.26756/th.2014.63eninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/32592020-11-20T08:43:23Z
spellingShingle Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
Hassan, Marwa Fouad Al
Metformin -- Therapeutic use
Astrocytomas
Brain -- Tumors
Cells -- Motility
Cell proliferation -- Drug effects
Cell adhesion
Lebanese American University -- Dissertations
Dissertations, Academic
status_str publishedVersion
title Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
title_full Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
title_fullStr Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
title_full_unstemmed Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
title_short Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
title_sort Metformin inhibits 2D and 3D motility in astrocytoma cancer cells. (c2014)
topic Metformin -- Therapeutic use
Astrocytomas
Brain -- Tumors
Cells -- Motility
Cell proliferation -- Drug effects
Cell adhesion
Lebanese American University -- Dissertations
Dissertations, Academic
url http://hdl.handle.net/10725/3259
https://doi.org/10.26756/th.2014.63